These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9661088)

  • 21. Flumazenil and seizures: analysis of 43 cases.
    Spivey WH
    Clin Ther; 1992; 14(2):292-305. PubMed ID: 1611650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need.
    Otto MW; Bruce SE; Deckersbach T
    J Clin Psychiatry; 2005; 66 Suppl 2():34-8. PubMed ID: 15762818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of age and sex on electroconvulsive therapy using remifentanil as the sole anesthetic agent.
    Hossain A; Sullivan P
    J ECT; 2008 Sep; 24(3):232-5. PubMed ID: 18562948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
    Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
    J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of conscious sedation by flumazenil: current status and future prospects.
    McCloy RF
    Acta Anaesthesiol Scand Suppl; 1995; 108():35-42. PubMed ID: 8693923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms.
    Anton RF; Myrick H; Baros AM; Latham PK; Randall PK; Wright TM; Stewart SH; Waid R; Malcolm R
    J Clin Psychopharmacol; 2009 Aug; 29(4):334-42. PubMed ID: 19593171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
    Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose benzodiazepine dependence: description of 29 patients treated with flumazenil infusion and stabilised with clonazepam.
    Quaglio G; Pattaro C; Gerra G; Mathewson S; Verbanck P; Des Jarlais DC; Lugoboni F
    Psychiatry Res; 2012 Aug; 198(3):457-62. PubMed ID: 22424905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data.
    Gallo AT; Hulse G
    J Psychopharmacol; 2021 Mar; 35(3):211-220. PubMed ID: 33426982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Depression and benzodiazepine dependence in the elderly. On the complexity of psychiatric manifestations and psychiatric treatment].
    Wolter-Henseler DK; Gadatsch MA; Schulte E
    Psychiatr Prax; 1994 Jul; 21(4):157-9. PubMed ID: 7938326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroconvulsive therapy in patients with epilepsy.
    Lunde ME; Lee EK; Rasmussen KG
    Epilepsy Behav; 2006 Sep; 9(2):355-9. PubMed ID: 16876485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of esmolol pretreatment on EEG seizure morphology in RUL ECT.
    McCall WV; Zvara D; Brooker R; Arias L
    Convuls Ther; 1997 Sep; 13(3):175-80. PubMed ID: 9342133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Predicting the success of a benzodiazepine discontinuation programme: myths or clinical wisdom?].
    Knoop H; Kan CC; Mickers FC; Barnhoorn D
    Tijdschr Psychiatr; 2006; 48(9):695-703. PubMed ID: 17007475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series.
    Hulse G; O'Neil G; Morris N; Bennett K; Norman A; Hood S
    J Psychopharmacol; 2013 Feb; 27(2):222-7. PubMed ID: 22596209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
    McGregor C; Machin A; White JM
    Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitation of ECT by intravenous administration of theophylline.
    Leentjens AF; van den Broek WW; Kusuma A; Bruijn JA
    Convuls Ther; 1996 Dec; 12(4):232-7. PubMed ID: 9034698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experience in the use of a benzodiazepine antagonist, flumazenil].
    Vabishchevich AV; Buniatian AA; Stamov VI; Kochneva ZV
    Anesteziol Reanimatol; 1997; (5):95-8. PubMed ID: 9432903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration.
    Makhinson M; Furst BA; Shuff MK; Kwon GE
    J ECT; 2012 Sep; 28(3):e35-6. PubMed ID: 22914637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzodiazepine dependence and its treatment with low dose flumazenil.
    Hood SD; Norman A; Hince DA; Melichar JK; Hulse GK
    Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.